Meanwhile the country’s newly appointed minister of health has been audacious in radically reshuffling the rules of the game to place public healthcare provision “firmly on a pathway to sustainability.” “A corner has been turned and we are well on the way to…
This report offers companies, investors, policymakers, and stakeholders crucial insight into the rich ecosystem of pharmaceuticals, biotech, and healthcare companies on Taiwan, based on in-depth interviews conducted with leaders and pioneers across the value chain, from…
This report offers companies, investors, policymakers, and stakeholders crucial insight into Switzerland; a country located at the heart of Europe, home to some of the world’s most important international health institutions as well as two of its largest pharmaceutical…
Greece Pharma Report
21/04/2017
This report offers companies, investors, policymakers, and stakeholders crucial insight into Greece; a country with an admirable and long-standing history in healthcare and pharmaceuticals, but one that is still struggling to find its way out of a national debt crisis. The…
This report offers companies, investors, policymakers, and stakeholders crucial insight into five companies at the cutting edge of Taiwan’s biotech industry: PharmaEngine, PharmaEssentia, OBI Pharma, SyneuRx, and TaiGen Biotechnology. The report features in-depth exclusive…
This report offers companies, investors, policymakers, and stakeholders crucial insight into Ireland; a nation that stands poised to cement its position as a premier pharmaceuticals power, not just within Europe, but globally. In addition to its blossoming R&D…
This special report offers companies, investors, policymakers, and stakeholders crucial insight into Central and Eastern Europe (CEE): a dynamic region, located strategically at the crossroads between Western Europe and the East, that has largely recovered from the global…
This report offers companies, investors, policymakers, and stakeholders crucial insight into Singapore; a nation that has had to carve out its own niche as a global trade hub and gateway to the Asia-Pacific region to compete globally since declaring independence in 1965. In…
This report offers companies, investors, policymakers, and stakeholders crucial insight into the Philippines; one of the most promising pharmaceutical markets in the Asia-Pacific region with a population of over 100 million, an annual GDP growth rate of around 6.5%, and a…
This report offers companies, investors, policymakers, and stakeholders crucial insight into Luxembourg; a country that is rapidly breaking away from its reputation as simply a tiny European tax haven and establishing itself as a serious regional and global healthcare and…
This report offers companies, investors, policymakers, and stakeholders crucial insight into Slovakia; a country with both political and economic stability; a Eurozone member that stands out in its region for being a member of the single currency; and, for the second half of…
This report offers companies, investors, policymakers, and stakeholders crucial insight into Switzerland; a country located at the heart of Europe, home to some of the world’s most important international health institutions as well as two of its largest pharmaceutical…